News
2021
Noveome Biotherapeutics, Inc. Announces Preliminary Results of its Phase 1 Open Label Clinical Trial Evaluating Intranasal Delivery of Lead Candidate ST266 In Glaucoma Suspect Patients, June 7 2021
2021
Dr. Iris Shichor recognized on Technology-Innovators' top 50 Healthcare Technology CEOs of 2021, June 2021
2021
Noveome Biotherapeutics, Inc. and SipNose, Ltd. Announce Commercial License Agreement For SipNose Cribriform Targeted Device June 1, 2021
2020
“Direct Delivery of Medications from the Upper Nasal Cavity into the Brain”
2019
Insulin Nasal Spray Trial Improves Alzheimer’s Symptoms, June 19, 2019
2019
“Pittsburgh company Noveome testing medication aimed at treating CTE”
2018
Pittsburgh, company gets $500K grant to start clinical trials